Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation

  1. Connolly, S.J.
  2. Karthikeyan, G.
  3. Nt, M.
  4. Haileamlak, A.
  5. El Sayed, A.
  6. El Ghamrawy, A.
  7. Damasceno, A.
  8. Avezum, A.
  9. Dans, A.M.L.
  10. Gitura, B.
  11. Hu, D.
  12. Kamanzi, E.R.
  13. Maklady, F.
  14. Fana, G.
  15. Gonzalez-Hermosillo, J.A.
  16. Musuku, J.
  17. Kazmi, K.
  18. Zühlke, L.
  19. Gondwe, L.
  20. Ma, C.
  21. Paniagua, M.
  22. Ogah, O.S.
  23. Molefe-Baikai, O.J.
  24. Lwabi, P.
  25. Chillo, P.
  26. Sharma, S.K.
  27. Cabral, T.T.J.
  28. Tarhuni, W.M.
  29. Benz, A.
  30. van Eikels, M.
  31. Krol, A.
  32. Pattath, D.
  33. Balasubramanian, K.
  34. Rangarajan, S.
  35. Ramasundarahettige, C.
  36. Mayosi, B.
  37. Yusuf, S.
  38. Show all authors +
Journal:
New England Journal of Medicine

ISSN: 1533-4406 0028-4793

Year of publication: 2022

Volume: 387

Issue: 11

Pages: 978-988

Type: Article

DOI: 10.1056/NEJMOA2209051 GOOGLE SCHOLAR

Sustainable development goals